デフォルト表紙
市場調査レポート
商品コード
1634174

明晰夢出現装置の世界市場 - 2025年~2033年

Global Lucid Dreaming Devices Market - 2025 - 2033


出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
明晰夢出現装置の世界市場 - 2025年~2033年
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

明晰夢出現装置の世界市場は、2023年に1億1,310万米ドルに達し、2033年には2億180万米ドルに達すると予測され、予測期間2025年~2033年のCAGRは5.8%で成長すると予測されています。

明晰夢出現装置は、睡眠パターンをモニターし、睡眠の特定の段階(多くの場合レム睡眠中)に感覚的な合図を送ることによって、個人が夢の状態を認識しコントロールするのを助ける装置です。これらの微妙な合図が夢の中での気づきの引き金となり、創造性、問題解決、自己認識を高める。明晰夢への関心が高まるにつれ、これらの装置は、創造性や問題解決能力の強化といった潜在的な利点から、愛好家や研究者の間で人気を博しています。

市場力学:

促進要因と抑制要因

技術進歩の台頭

ウェアラブル技術、AI統合、睡眠モニタリングセンサーなどの技術進歩により、明晰夢出現装置の精度と効率が大幅に向上しています。これらのツールは現在、リアルタイムの睡眠パターンを分析し、明晰夢を誘発するのに最適なタイミングで感覚的な合図を送るスマートなアルゴリズムを備えています。素材と小型化によって、これらのデバイスはより快適で身近なものになった。モバイル・アプリケーションとクラウドベースのプラットフォームが統合されたことで、詳細な睡眠分析、パーソナライズされたフィードバック、コミュニティとの交流など、ユーザー・エクスペリエンスが向上しています。このような技術的躍進が市場の成長を促し、明晰夢出現装置の潜在的用途を拡大しています。

例えば2024年2月、PropheticAIは明晰夢をコントロールする世界初の超音波トランスフォーマー、Haloヘッドバンドを開発しました。この装置は、EEGとFMRIの同時計測というユニークな神経画像技術を用い、時間的に対応したデータセットを同時に取得します。これによりPropheticAIは、神経発火パターンを複製し、明晰夢に関連するような特定の脳状態を誘導するMorpheus 1を構築することができます。EEGとFMRIデータで訓練された生成的超音波トランスフォーマーアーキテクチャは、人間の意識を理解する上で大きな飛躍となります。

認知度の低さ

世界の明晰夢出現装置市場は、認知度の低さとその効果に対する懐疑的な見方により、大きな課題に直面しています。創造性、問題解決、治療への応用など、明晰夢を見ることのメリットを知らない人が多いです。教育キャンペーンや睡眠科学に関する主流の議論がないことが、この問題をさらに悪化させています。市場の潜在的成長力を引き出すには、ターゲットを絞ったマーケティング、睡眠研究者との協力、一般市民への啓蒙活動が不可欠です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 技術進歩の高まり
    • 抑制要因
      • 広範な認識の欠如
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 デバイスタイプ別

  • ウェアラブルデバイス
    • ヘッドバンド
    • 眼鏡
    • マスク
  • 非ウェアラブルデバイス
    • スマートフォンアプリ
    • ヘッドフォンベースのシステム
    • 睡眠モニタリングシステム

第7章 技術別

  • 脳波検査(EEG)装置
  • 感覚刺激装置
  • 光ベース
  • サウンドベース
  • 触覚刺激
  • 神経刺激装置

第8章 用途別

  • 個人使用
  • 治療目的の使用

第9章 流通チャネル別

  • オンライン販売
  • 専門店
  • 直接販売

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Lucid Dreamer
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • Dream Leaf
  • Neuroon
  • Remee
  • HOBOT
  • NovaDreamer
  • Sleep Shepherd
  • Mind Awake
  • SunSleep
  • iWinks

第12章 付録

目次
Product Code: MD8979

The global lucid dreaming devices market reached US$ 113.1 million in 2023 and is expected to reach US$ 201.8 million by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

Lucid dreaming devices are devices that help individuals recognize and control their dream state by monitoring sleep patterns and delivering sensory cues during specific stages of sleep, often during REM sleep. These subtle cues trigger awareness within the dream, enhancing creativity, problem-solving, and self-awareness. With growing interest in lucid dreaming, these devices have gained popularity among enthusiasts and researchers due to potential benefits such as enhanced creativity and problem-solving abilities.

Market Dynamics: Drivers & Restraints

Rise in Technological Advancements

Technological advancements in wearable technology, AI integration, and sleep-monitoring sensors have significantly improved the precision and efficiency of lucid dreaming devices. These tools now feature smart algorithms that analyze real-time sleep patterns, delivering sensory cues at the optimal moment for inducing lucid dreams. Materials and miniaturization have made these devices more comfortable and accessible. The integration of mobile applications and cloud-based platforms enhances user experience with detailed sleep analytics, personalized feedback, and community interaction. These technological breakthroughs are driving market growth and expanding the potential applications of lucid dreaming devices.

For instance, in February 2024, PropheticAI has developed the Halo headband, the world's first ultrasonic Transformer, to control lucid dreaming. The device uses a unique neuroimaging technique, simultaneous EEG and FMRI, to capture a simultaneous dataset with temporal correspondence. This allows PropheticAI to build Morpheus 1, which replicates neural firing patterns, inducing specific brain states, such as those associated with lucid dreaming. The generative ultrasonic Transformer architecture, trained on EEG and FMRI data, is a significant leap in understanding human consciousness.

Lack of Widespread Awareness

The global lucid dreaming devices market faces significant challenges due to a lack of awareness and skepticism about its effectiveness. Many people are unaware of the benefits of lucid dreaming, such as creativity, problem-solving, and therapeutic applications. The absence of educational campaigns and mainstream discussions about sleep science further exacerbates this issue. To unlock the market's growth potential, targeted marketing, collaboration with sleep researchers, and public education initiatives are essential.

Segment Analysis

The global lucid dreaming devices market is segmented based on device type, technology, application, distribution channel and region.

Device Type:

Wearable Devices segment is expected to dominate the Lucid Dreaming Devices market share

The wearable devices segment holds a major portion of the lucid dreaming devices market share and is expected to continue to hold a significant portion of the lucid dreaming devices market share during the forecast period.

The global lucid dreaming devices market is dominated by wearable devices, driven by advancements in technology and consumer preferences for compact, user-friendly solutions. These devices, including headbands, smart masks, and wristbands, use advanced sensors to monitor sleep stages and deliver precise sensory cues for inducing lucid dreams. The growing popularity of wearable technology in health and wellness has increased consumer trust and interest in these products. The seamless integration of wearable devices with mobile applications offers real-time sleep analytics, personalized feedback, and enhanced convenience. The portability and comfort of wearables make them attractive to a broad audience.

Technology

Electroencephalography (EEG) Devices segment is the fastest-growing segment in Lucid Dreaming Devices market share

The electroencephalography (eeg) devices segment is the fastest-growing segment in the lucid dreaming devices market share and is expected to hold the market share over the forecast period.

Electroencephalography (EEG) technology is revolutionizing the global lucid dreaming devices market by enabling precise monitoring and analysis of brain activity during sleep. These devices detect brainwave patterns associated with various sleep stages, particularly REM sleep, where dreaming occurs. By delivering targeted sensory cues, EEG technology enhances the efficacy of lucid dreaming devices, making them valuable tools for researchers and enthusiasts. The integration of EEG technology with advanced machine learning algorithms and mobile applications allows for personalized feedback and deeper understanding of sleep patterns, positioning EEG-based lucid dreaming devices as a key driver of market growth.

Geographical Analysis

North America is expected to hold a significant position in the Lucid Dreaming Devices market share

North America holds a substantial position in the lucid dreaming devices market and is expected to hold most of the market share due to high adoption of advanced sleep technologies and growing awareness of mental health and wellness. The region's established consumer electronics industry and leading manufacturers and startups in sleep innovation drive market growth. Increased investments in wearable and EEG-based devices, alternative therapies, and strong consumer spending on health and wellness products create a favorable environment for market expansion. Supportive initiatives from sleep research organizations and widespread distribution channels further support lucid dreaming device adoption.

For instance, in April 2024, Utah-based startup DreamRing Labs has launched a device called DreamRing, which uses non-invasive magnetic stimulation to enhance lucid dreaming experiences. The device, which can be pre-ordered, boosts dream clarity and conscious awareness in just 15 minutes before bed. The device has been proven effective in increasing lucid dreaming frequency and improving sleep quality.

Europe is growing at the fastest pace in the Lucid Dreaming Devices market

Europe holds the fastest pace in the lucid dreaming devices market and is expected to hold most of the market share due to a rise in the prevalence of sleep disorders, growing focus on sleep health and innovative wellness solutions. The region's robust regulatory framework, increasing awareness campaigns, and interest in mindfulness and cognitive enhancement support market growth. Europe's strong academic and research presence, collaborations between manufacturers and universities, and demand for sustainable and aesthetically designed products also contribute to the market's growth.

For instance, according to NCBI study, Sleep deprivation is a significant public health issue in France, with 28% of adults experiencing sleep debt and 18.5% experiencing excessive daytime sleepiness. Chronic insomnia is a significant public health concern, with 13% of the population having a diagnosis and 19% describing symptoms. Additionally, the prevalence of OSAS is 4.8% in the French population and restless legs syndrome is 8.5%.

Competitive Landscape

The major global players in the lucid dreaming devices market include Lucid Dreamer, Dream Leaf, Neuroon, Remee, HOBOT, NovaDreamer, Sleep Shepherd, Mind Awake, SunSleep, iWinks and among others.

Key Developments

  • In July 2024, REMspace, a neurotechnology company focusing on lucid dreaming studies, has closed a $1M seed round raised from European lucid dreaming practitioners and enthusiasts. The capital will be used to develop software and hardware for REMspace's research and commercial projects, including dietary supplements and its smart sleeping mask. The capital will also be used to unveil new technology and services to enhance customers' lucid dreaming practices.
  • In November 2024, A study published in the journal Consciousness and Cognition by Northwestern University demonstrates that "Targeted Lucidity Reactivation" (TLR) can help people remember their dreams and even lead them into the subconscious. The app involves training people to associate a specific sound with dreaming awareness, which is then played while subjects are asleep. The study involved 19 participants who previously remembered their dreams upon waking, and 416 participants who were not in the waking world.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global lucid dreaming devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by Distribution Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Widespread Awareness
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Device Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 6.1.2. Market Attractiveness Index, By Device Type
  • 6.2. Wearable Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Headbands
    • 6.2.4. Glasses
    • 6.2.5. Masks
  • 6.3. Non-Wearable Devices
    • 6.3.1. Smartphone Apps
    • 6.3.2. Headphone-based systems
    • 6.3.3. Sleep monitoring systems

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Electroencephalography (EEG) Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Sensory Stimulation Devices
  • 7.4. Light-based
  • 7.5. Sound-based
  • 7.6. Tactile stimulation
  • 7.7. Neurostimulation Devices

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Personal Use*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Therapeutic Use

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Online Sales*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Stores
  • 9.4. Direct Sales

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Lucid Dreamer*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Dream Leaf
  • 12.3. Neuroon
  • 12.4. Remee
  • 12.5. HOBOT
  • 12.6. NovaDreamer
  • 12.7. Sleep Shepherd
  • 12.8. Mind Awake
  • 12.9. SunSleep
  • 12.10. iWinks

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us